Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement | Akebia Therapeutics has struck a deal for Q32 ...

Belite linked tinlarebant to a 35.7% reduction in lesion growth rate versus placebo, achieving the study’s primary endpoint.

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as ...

South Korean biotech companies are gaining prominence in the global bio-technology market. According to JP Morgan, Seoul ...

In conjunction with Tract’s move to Connect Labs Charlotte, the company’s scientific co-founders, Frank McKeon, Ph.D., and Wa ...

Indiana shows high potential for the state to become the premiere destination to research, commercialize, scale biotechnology ...

RESEARCH TRIANGLE PARK – The North Carolina Biotechnology Center and a host of partners showcased the strengths of North Carolina’s life sciences community at BIO 2023, the international biotechnology ...

The Biotechnology Innovation Organization (BIO) announced this week it appointed John Crowley, founder and executive chairman of Cranbury-based Amicus Therapeutics, as its new president and CEO, ...

CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...

Biotechnology can be used in the packaging of beauty products and has a significant sustainability impact that is good for ...